, , , , , ,

Image of the day: Crash 3 Trial


NEW Research in The Lancet | CRASH-3 trial provides evidence that tranexamic acid, a low-cost drug, could prevent deaths from TBI by as much as 20% depending on severity of the injury https://ift.tt/2VVwbU1 Worldwide, roughly 69 million people will experience a traumatic brain injury (TBI) each year. CRASH-3 was one of the largest head injury clinical trials ever conducted and led by London School of Hygiene & Tropical Medicine showed that a low-cost drug could prevent deaths from TBI by as much as 20% depending on severity of the injury. Tranexamic acid (TXA) was most effective in mild-moderate head injuries but showed no clear impact in severely injured patients. It’s also safe to give and is most effective the earlier it is given. If TXA is given to all TBI patients immediately after injury, it could prevent tens or hundreds of thousands of deaths around the globe each year. via WSF Instagram

0 comments:

Post a Comment

Please let us know what you think about this post

Topics